PRELUDE TO A CURE, INC.
TAMPA, FLORIDA

PRELUDE TO A CURE, INC., Tampa

The Ribbon is White Bring it to Light mission to create this remarkable website was made possible thanks to the generous support of our sponsors and contributors. On behalf of Prelude to a Cure and the Ribbon is White Committee, THANK YOU for supporting this project. Prelude to a Cure is the brainchild of Dr. Lary Robinson, one of Florida’s premier thoracic surgeons, who joined forces with a nationally renowned thoracic researcher, Dr. Scott Antonia to create Prelude to a Cure, a 501(c)(3) organization. We consider them our intrepid explorers, as both are recognized for discovering and identifying unique strategies for the treatment of lung cancer patients. This willingness to search in unexpected places translates to lives saved. Their efforts are 100% voluntary and 100% of your contributions go to the cause: finding a cure to the number one cancer killer, lung cancer — a quest that can only be realized with essential funding for this life saving research. Prelude to a Cure, Inc. is a Nonprofit 501(c)(3) Charity helping to fund lung cancer research which may make your contributions tax deductible.

KEY FACTS ABOUT PRELUDE TO A CURE, INC.

Company name
PRELUDE TO A CURE, INC.
Status
Inactive
Filed Number
N12000007946
FEI Number
46-0803747
Date of Incorporation
August 16, 2012
Home State
FL
Company Type
Domestic Non Profit

CONTACTS

Website
http://preludetoacure.com

PRELUDE TO A CURE, INC. NEAR ME

Principal Address
509 West Bay St.,
Unit 306,
Tampa,
FL,
33606,
US
Mailing Address
Prelude to a Cure,
P.O. Box 320145,
Tampa,
FL,
33679,
US

See Also

Officers and Directors

The PRELUDE TO A CURE, INC. managed by the three persons from TAMPA, Lutz, Brandon on following positions: President, Co-T, Dire

Lary A Robinson

Position
President Active
From
TAMPA, 33647

Deanna Grubbs

Position
Co-T Active
From
Lutz, 33559

Debbie Ploor

Position
Dire Active
From
Brandon, 33511





Registered Agent is Rosalynne I Miller

From
Tampa, 33679

Events

September 23, 2022
ADMIN DISSOLUTION FOR ANNUAL REPORT
March 21, 2013
AMENDED AND RESTATEDARTICLES

Annual Reports

2021
February 4, 2021
2020
September 4, 2020